In this study, we used the second-generation tau radiotracer 18F-Florzolotau to evaluate the relationship between the abnormal FC (including functional connection strength and PLFCS) and tau deposition, as well as neuropsychological scores in AD and MCI, and further explored the role of tau accumulation in the FC abnormality during AD disease progression. Here, MAPT is linked to Alzheimer disease.